Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Controlled Clinical Trial Investigating the Effect of Reduced Bleomycin in Elechtrochemotherapy Treatment on Patients With Cutaneous Malignancies (The BLESS Trial)

NCT06647342 is registered in ClinicalTrials.gov with Julie Gehl as lead sponsor.

NCT NCT06647342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06647342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Controlled Clinical Trial Investigating the Effect of Reduced Bleomycin in Elechtrochemotherapy Treatment on Patients With Cutaneous Malignancies (The BLESS Trial)
Lead sponsor
Julie Gehl
Phase
Phase 4
Overall status
Recruiting
Start date
October 29, 2024
Completion date
December 31, 2027
Enrollment
55 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bleomycin adverse reaction, cutaneous malignant mixed tumor, cutaneous metastasis, electrochemotherapy